ImmunoPrecise Antibodies (IPA) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ImmunoPrecise Antibodies Earnings Summary ImmunoPrecise Antibodies announced Q4 2025 earnings on July 29, 2025, reporting an EPS of -$0.04, which missed analysts' consensus estimates of -$0.02 by $0.02. Quarterly revenue was reported to be $5.06 million, below analyst estimates of $7.89 million. With a trailing EPS of -$0.68, ImmunoPrecise Antibodies' earnings are expected to grow next year, from ($0.27) to ($0.13) per share. Upcoming Q1 Earnings DateSep. 15Before Market OpensEstimatedConsensus EPS (Jul. 29) -$0.02 Actual EPS (Jul. 29) -$0.04 Missed By -$0.02 Actual Revenue (Jul. 29) $5.06MQ4 2025 Earnings ResourcesQ4 2025 Earnings ReportConference Call Transcript & Audio Annual Report (20-F) Press Release (8-K) Press Release (6-K)IPA Upcoming EarningsImmunoPrecise Antibodies' Q1 2026 earnings is scheduled for Monday, September 15, 2025, with a conference call scheduled at 10:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2026 Earnings ReportPowered by Get ImmunoPrecise Antibodies Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ImmunoPrecise Antibodies and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataIPA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IPA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. ImmunoPrecise Antibodies Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.09-$0.09-$0.09Q2 20251-$0.05-$0.05-$0.05Q3 20251-$0.06-$0.06-$0.06Q4 20251-$0.02-$0.02-$0.02 FY 2025 4 -$0.22 -$0.22 -$0.22 Q1 20261-$0.04-$0.04-$0.04Q2 20261-$0.01-$0.01-$0.01Q3 20261$0.00$0.00$0.00Q4 20261$0.01$0.01$0.01 ImmunoPrecise Antibodies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 9/15/2025(Estimated)-------7/29/2025Q4 2025-$0.02-$0.04 -$0.02-$0.04$7.89M$5.06M3/28/2025Q3 2025-$0.06-$0.06--$0.46$6.59M$4.23M12/10/2024Q2 2025-$0.05-$0.07 -$0.02-$0.07--9/16/2024Q1 2025-$0.09-$0.11 -$0.02-$0.11$4.96M$3.85M7/29/2024Q4 2024-$0.10-$0.52 -$0.42-$0.52$4.92M$4.76M3/14/2024Q3 2024-$0.08-$0.08--$0.08$4.43M$4.60M12/14/2023Q2 2024-$0.09-$0.07+$0.02-$0.07$4.44M$4.50M9/14/2023Q1 2024-$0.17-$0.11+$0.06-$0.11$3.98M$4.26M ImmunoPrecise Antibodies Earnings - Frequently Asked Questions When is ImmunoPrecise Antibodies' earnings date? ImmunoPrecise Antibodies has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, September 15th, 2025 based off last year's report dates. Learn more on IPA's earnings history. Did ImmunoPrecise Antibodies beat their earnings estimates last quarter? In the previous quarter, ImmunoPrecise Antibodies (NASDAQ:IPA) missed the analysts' consensus estimate of ($0.02) by $0.02 with a reported earnings per share (EPS) of ($0.04). Learn more on analysts' earnings estimate vs. IPA's actual earnings. How can I listen to ImmunoPrecise Antibodies' earnings conference call? The conference call for ImmunoPrecise Antibodies' latest earnings report can be listened to online. Listen to Conference Call How can I read ImmunoPrecise Antibodies' conference call transcript? The conference call transcript for ImmunoPrecise Antibodies' latest earnings report can be read online. Read Transcript How much revenue does ImmunoPrecise Antibodies generate each year? ImmunoPrecise Antibodies (NASDAQ:IPA) has a recorded annual revenue of $17.59 million. How much profit does ImmunoPrecise Antibodies generate each year? ImmunoPrecise Antibodies (NASDAQ:IPA) has a recorded net income of -$21.69 million. IPA has generated -$0.68 earnings per share over the last four quarters. What is ImmunoPrecise Antibodies' EPS forecast for next year? ImmunoPrecise Antibodies' earnings are expected to grow from ($0.27) per share to ($0.13) per share in the next year. More Earnings Resources from MarketBeat Related Companies CTMX Earnings Results DSGN Earnings Results MBX Earnings Results BNTC Earnings Results IMAB Earnings Results UPXI Earnings Results RCKT Earnings Results ABEO Earnings Results CGC Earnings Results FDMT Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Celsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 EarningsWhy Broadcom's Q3 Earnings Were a Huge Win for AVGO BullsAffirm Crushes Earnings Expectations, Turns Bears into BelieversAmbarella's Earnings Prove Its Edge AI Strategy Is a WinnerWhat to Watch for From D-Wave Now That Earnings Are DoneDICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? This page (NASDAQ:IPA) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.